1. Bladder function after radical hysterectomy for cervical cancer. Issue 4 (12th February 2014) Authors: Laterza, Rosa M.; Sievert, Karl‐Dietrich; de Ridder, Dirk; Vierhout, Mark E.; Haab, Francois; Cardozo, Linda; van Kerrebroeck, Philip; Cruz, Francisco; Kelleher, Con; Chapple, Christopher; Espuña‐Pons, Montserrat; Koelbl, Heinz Journal: Neurourology and urodynamics Issue: Volume 34:Issue 4(2015:Apr.) Page Start: 309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative efficacy and tolerability of solifenacin 5 mg/day versus other oral antimuscarinic agents in overactive bladder: A systematic literature review and network meta‐analysis. Issue 3 (15th November 2017) Authors: Nazir, Jameel; Kelleher, Con; Aballéa, Samuel; Maman, Khaled; Hakimi, Zalmai; Mankowski, Colette; Odeyemi, Isaac Journal: Neurourology and urodynamics Issue: Volume 37:Issue 3(2018:Mar.) Page Start: 986 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK. Issue 1 (1st January 2018) Authors: Hakimi, Zalmai; Kelleher, Con; Aballéa, Samuel; Maman, Khaled; Nazir, Jameel; Mankowski, Colette; Odeyemi, Isaac Journal: Journal of market access & health policy Issue: Volume 6:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Development of an overactive bladder assessment tool (BAT): A potential improvement to the standard bladder diary. Issue 5 (23rd January 2018) Authors: Kelleher, Con; Chapple, Christopher; Johnson, Nathan; Payne, Christopher; Homma, Yukio; Hakimi, Zalmai; Siddiqui, Emad; Evans, Christopher; Egan, Shayna; Kopp, Zoe Journal: Neurourology and urodynamics Issue: Volume 37:Issue 5(2018:Jun.) Page Start: 1701 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy of fesoterodine compared with extended‐release tolterodine in men and women with overactive bladder. (4th July 2013) Authors: Ginsberg, David; Schneider, Tim; Kelleher, Con; Van Kerrebroeck, Philip; Swift, Steven; Creanga, Dana; Martire, Diane L. Journal: BJU international Issue: Volume 112:Number 3(2013:Aug.) Page Start: 373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Gynaecology. Issue 7211 (11th September 1999) Authors: Kelleher, Con; Braude, Peter Journal: BMJ Issue: Volume 319:Issue 7211(1999) Page Start: 689 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Oral pharmacotherapy for overactive bladder in older patients: mirabegron as a potential alternative to antimuscarinics. (2nd April 2016) Authors: Wagg, Adrian; Nitti, Victor W.; Kelleher, Con; Castro-Diaz, David; Siddiqui, Emad; Berner, Todd Journal: Current medical research and opinion Issue: Volume 32:Number 4(2016:Apr.) Page Start: 621 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Patient‐reported outcomes from SYNERGY, a randomized, double‐blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients. Issue 1 (13th July 2017) Authors: Robinson, Dudley; Kelleher, Con; Staskin, David; Mueller, Elizabeth R.; Falconer, Christian; Wang, Jianye; Ridder, Arwin; Stoelzel, Matthias; Paireddy, Asha; van Maanen, Rob; Hakimi, Zalmai; Herschorn, Sender Journal: Neurourology and urodynamics Issue: Volume 37:Issue 1(2018:Jan.) Page Start: 394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗